rs118203380
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000368.5(TSC1):c.395_406delGCGTCTTGGTGTinsCA(p.Gly132AlafsTer2) variant causes a frameshift, missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. G132G) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000368.5 frameshift, missense
Scores
Clinical Significance
Conservation
Publications
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- lung lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000368.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC1 | NM_000368.5 | MANE Select | c.395_406delGCGTCTTGGTGTinsCA | p.Gly132AlafsTer2 | frameshift missense | Exon 6 of 23 | NP_000359.1 | ||
| TSC1 | NM_001406592.1 | c.395_406delGCGTCTTGGTGTinsCA | p.Gly132AlafsTer2 | frameshift missense | Exon 6 of 23 | NP_001393521.1 | |||
| TSC1 | NM_001406593.1 | c.395_406delGCGTCTTGGTGTinsCA | p.Gly132AlafsTer2 | frameshift missense | Exon 6 of 23 | NP_001393522.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC1 | ENST00000298552.9 | TSL:1 MANE Select | c.395_406delGCGTCTTGGTGTinsCA | p.Gly132AlafsTer2 | frameshift missense | Exon 6 of 23 | ENSP00000298552.3 | ||
| TSC1 | ENST00000490179.4 | TSL:3 | c.395_406delGCGTCTTGGTGTinsCA | p.Gly132AlafsTer2 | frameshift missense | Exon 7 of 24 | ENSP00000495533.2 | ||
| TSC1 | ENST00000403810.6 | TSL:1 | c.395_406delGCGTCTTGGTGTinsCA | p.Gly132AlafsTer2 | frameshift missense | Exon 6 of 10 | ENSP00000386093.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Tuberous sclerosis 1 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gly132Alafs*2) in the TSC1 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals in the Leiden Open-source Variation Database (PMID: 21520333). Loss-of-function variants in TSC1 are known to be pathogenic (PMID: 10227394, 17304050). For these reasons, this variant has been classified as Pathogenic.
Tuberous sclerosis syndrome Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at